LUBRIZOL SELLS ACTIVE PHARMACEUTICAL INGREDIENT AND INTERMEDIATE COMPOUNDS BUSINESS

The Lubrizol Corporation announced today that it has agreed to sell its active pharmaceutical ingredient and intermediate compounds business, with facilities in Raubling, Germany and Chennai, India (A&I). The purchasers are Auctus Management GmbH (Auctus), a German private equity firm located in Munich, Germany, and the current management of the active pharmaceutical ingredient business. KeyBanc Capital Markets advised Lubrizol on the transaction. PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/03-31-2006/0004330756&EDATE=)